These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 18039083

  • 1. Treatment of anaerobic infection.
    Brook I.
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):991-1006. PubMed ID: 18039083
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antimicrobial treatment of anaerobic infections.
    Brook I.
    Expert Opin Pharmacother; 2011 Aug; 12(11):1691-707. PubMed ID: 21506900
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
    Fraise AP.
    J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA, Fasching CE, Sinn LM, Gerding DN, Peterson LR.
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance.
    Aldridge KE.
    Eur J Surg Suppl; 1994 Feb; (573):31-7. PubMed ID: 7524793
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Role of obligate anaerobes in infections in hospitalized patients and therapeutic options].
    Wróblewska M, Rokosz A, Sawicka-Grzelak A, Kot K, Luczak M.
    Med Dosw Mikrobiol; 2005 Feb; 57(2):199-208. PubMed ID: 16134392
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
    Behra-Miellet J, Dubreuil L, Calvet L.
    Int J Antimicrob Agents; 2006 Jul; 28(1):25-35. PubMed ID: 16757152
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.